Propranolol for migraine prophylaxis

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Linde, Klaus ^a   Rossnagel, Karin ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Adrenergic beta antagonists *therapeutic use ; Adult; Calcium channel blockers therapeutic use ; Humans; Migraine disorders *prevention control ; Propranolol *therapeutic use ; Randomized controlled trials as topic; Treatment refusal

Indexed keywords

5 HYDROXYTRYPTOPHAN; AMITRIPTYLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CYCLANDELATE; FEMOXETINE; FLUNARIZINE; NADOLOL; NAPROXEN; NIFEDIPINE; PLACEBO; PROPRANOLOL; TOLFENAMIC ACID;

CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; MIGRAINE; PROPHYLAXIS; REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 77950146857     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003225.pub2     Document Type: Review

References (111)

1. Ahuja 1985 {published data only} Ahuja GK, Verma AK. Propranolol in prophylaxis of migraine. Indian Journal of Medical Research 1985;82:263-5.
2. Al-Qassab 1993 {published data only} Al-Qassab HK, Findley LJ. Comparison of propranolol LA 80 mg and propranolol LA 160 mg in mirgraine prophylaxis: a placebo controlled study. Cephalalgia 1993;13(2):128-31.
3. Albers 1989 {published data only} Albers GW, Simon LT, Hamik A, Peroutka SJ. Nifedipine versus propranolol for the initial prophylaxis of migraine. Headache 1989;29(4):215-8.
4. Andersson 1981 {published data only} Andersson PG, Petersen EN. Propranolol and femoxetine, a 5HT-uptake inhibitor, in migraine prophylaxis. A double-blind crossover study. Acta Neurologica Scandinavica 1981;64(4):280-8.
5. Baldrati 1983 {published data only} Baldrati A, Cortelli P, Procaccianti G, Gamberini G, D'Alessandro R, Baruzzi A, et al.Propranolol and acetylsalicylic acid in migraine prophylaxis. Double-blind crossover study. Acta Neurologica Scandinavica 1983;67(3):181-6.
6. Behan 1980 {published data only} Behan PO, Reid M. Propranolol in the treatment of migraine. Practitioner 1980;224(1340):201-3.
7. Bonuso 1998 {published data only} Bonuso S, Di Stasio E, Marano E, de Angelis S, Amato D, Scellini T. Long-term outcome of migraine therapy: predictive value of the frontotemporal nitroglycerin test. Neurology 1998;51(5):1475-8.
8. Bordini 1997 {published data only} Bordini CA, Arruda MA, Ciciarelli MC, Speciali JG. Propranolol vs flunarizine vs flunarizine plus propranolol in migraine without aura prophylaxis. A double-blind trial. Arquivos de Neuro-Psiquiatria 1997;55(3B):536-41.
9. Borgesen 1974 {published data only} Borgesen SE. Treatment of migraine with propranolol. Postgraduate Medical Journal 1976;52 Suppl 4(0):163-5.
10. * Borgesen SE, Nielsen JL, Moller CE. Prophylactic treatment of migraine with propranolol. A clinical trial. Acta Neurologica Scandinavica 1974;50(5):651-6.
11. Borgesen SE, Nielsen JL, Moller CE. Propranolol in migraine. Lancet 1974;2(7871):58.
12. Dahlöf 1987 {published data only} Dahlöf C. No clearcut longterm prophylactic effect of one month of treatment with propranolol in migraineurs. Cephalalgia 1987;7 Suppl 6:459-60.
13. Diamond 1976 {published data only} Diamond S, Medina JL. Double blind study of propranolol for migraine prophylaxis. Headache 1976;16(1):24-7.
14. Diamond 1982 {published data only} Diamond S, Kudrow L, Stevens J, Shapiro DB. Long-term study of propanolol in the treatment of migraine. Headache 1982;22(6):268-71.
15. Diener 1989 {published data only} * Diener HC, Scholz E, Dichgans J, Gerber WD, Jäck A, Bille A, et al.Central effects of drugs used in migraine prophylaxis evaluated by visual evoked potentials. Annals of Neurology 1989;25(2):125-30.
16. Gerber WD, Diener HC, Scholz E, Niederberger U. Responders and non-responders to metoprolol, propanolol and nifidepine treatment in migraine prophylaxis: a dose-range study based on time-series analysis. Cephalalgia 1991;11(1):37-45.
17. Diener 1996 {published data only} Diener HC, Foh M, Iaccarino C, Wessely P, Isler H, Strenge H, et al.Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propanolol. Cephalalgia 1996;16(6): 441-7.
18. Diener 2002 {published data only} Diener HC. Efficacy and tolerability of flunarizine and propranolol in the prophylactic treatment of migraine. Cephalalgia 1999;19(4):374.
19. * Diener HC, Matias-Guiu J, Hartung E, Pfaffenrath V, Ludin HP, Nappi G, et al.Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily [published erratum appears in Cephalalgia 2002;22(6):488]. Cephalalgia 2002;22(3): 209-21.
20. Formisano 1991 {published data only} Formisano R, Falaschi P, Cerbo R, Proietti A, Catarci T, D'Urso R, et al.Nimodipine in migraine: clinical efficacy and endocrinological effects. European Journal of Clinical Pharmacology 1991;41(1):69-71.
21. Forssman 1976 {published data only} Forssman B, Henriksson KG, Johannsson V, Lindvall L, Lundin H. Propranolol for migraine prophylaxis. Headache 1976;16(5):238-45.
22. Gawel 1992 {published data only} Gawel M, Kreeft J, Nelson R, Simard D. Flunarizine is comparable to propranolol in the prophylaxis of migraine with and without aura. Cephalalgia 1991;11 Suppl 11:156.
23. * Gawel MJ, Kreeft J, Nelson RF, Simard D, Arnott WS. Comparison of the efficacy and safety of flunarizine to propranolol in the prophylaxis of migraine. Canadian Journal of Neurological Sciences 1992;19(3): 340-5.
24. Gerber 1995 {published data only} * Gerber WD, Schellenberg R, Thom M, Haufe C, Bölsche F, Wedekind W, et al.Cyclandelate versus propranolol in the prophylaxis of migraine - a double-blind placebo-controlled study. Functional Neurology 1995;10(1):27-35.
25. Schellenberg R, Schwarz A, Niederberger U, Bölsche F, Schindler M, Gerber WD, et al.On the long-term effect of cyclandelate and propranolol in migraine after stopping a four-month drug prophylaxis [Zur Langzeitwirkung von Cyclandelat und Propranolol bei Migräne nach Beendigung einer viermonatigen medikamentösen Prophylaxe]. Nervenheilkunde 1997;16:183-7.
26. Grotemeyer 1987 {published data only} Grotemeyer KH, Husstedt IW, Schlake HP. Betablocker vs placebo in vasomotor headache. A double-blind crossover study [Betablocker vs Placebo bei vasomotorischem Kopfschmerz. Eine doppelblinde Cross-over-Studie]. Deutsche Medizinische Wochenschrift 1987;112(45):1740-3.
27. Hedman 1986 {published data only} Hedman C, Winther K, Knudsen JB. The difference between nonselective and beta 1-selective beta-blockers in their effect on platelet function in migraine patients. Acta Neurologica Scandinavica 1986;74(6):475-8.
28. Holdorff 1977 {published data only} Holdorff B, Sinn M, Roth G. Propranolol for migraine prophylaxis: a double-blind study [Propranolol in der Migräneprophylaxe. Eine Doppelblindstudie]. Medizinische Klinik 1977;72(25):1115-8.
29. Johnson 1986 {published data only} Johnson RH, Hornabrook RW, Lambie DG. Comparison of mefenamic acid and propranolol with placebo in migraine prophylaxis. Acta Neurologica Scandinavica 1986;73(5): 490-2.
30. Kangasniemi 1983 {published data only} Kangasniemi PJ, Nyrke T, Lang AH, Petersen E. Femoxetine - a new 5-HT uptake inhibitor - and propranolol in the prophylactic treatment of migraine. Acta Neurologica Scandinavica 1983;68(4):262-7.
31. Kangasniemi 1984 {published data only} * Kangasniemi P, Hedman C. Metoprolol and propranolol in the prophylactic treatment of classical and common migraine. A double-blind study. Cephalalgia 1984;4(2):91-6.
32. Nyrke T, Kangasniemi P, Lang AH, Petersen E. Steady-state visual evoked potentials during migraine prophylaxis by propranolol and femoxetine. Acta Neurologica Scandinavica 1984;69(1):9-14.
33. Kaniecki 1997 {published data only} Kaniecki RG. A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura. Archives of Neurology 1997;54(9):1141-5.
34. Kass 1980 {published data only} Kass B, Nestvold K. Propranolol (Inderal) and clonidine (Catapressan) in the prophylactic treatment of migraine. A comparative trial. Acta Neurologica Scandinavica 1980;61(6):351-6.
35. Kjaersgard 1994 {published data only} Kjaersgard Rasmussen MJ, Holt Larsen B, Borg L, Soelberg Sorensen P, Hansen PE. Tolfenamic acid versus propranolol in the prophylactic treatment of migraine. Acta Neurologica Scandinavica 1994;89(6):446-50.
36. Klapper 1994 {published data only} Klapper JA. An open label cross-over comparison of divalproex sodium and propranolol HCl in the prevention of migraine headaches. Headache Quarterly 1994;5(1):50- 3.
37. Kuritzky 1987 {published data only} Kuritzky A, Hering R. Prophylactic treatment of migraine with long acting propranolol - a comparison with placebo. Cephalalgia 1987;7 Suppl 6:457-8.
38. Ludin 1989 {published data only} Ludin HP. Flunarizine and propranolol in the treatment of migraine. Headache 1989;29(4):219-24.
39. Lücking 1988a {published data only} * Lücking CH, Oestreich W, Schmidt R, Soyka D. Flunarizine versus propranolol in the prophylaxis of migraine: two double-blind comparative studies in more than 400 patients. Cephalalgia 1988;8(Suppl 8):21-6.
40. Soyka D, Oestreich W. Flunarizine versus propranolol in migraine prophylaxis - A multicenter double-blind study in 12 hospitals [Flunarizin versus Propranolol in der Intervallprophylaxe der Migräne - eine multizentrische Doppelblindstudie in 12 Kliniken]. Nervenheilkunde 1987;6:177-83.
41. Lücking 1988b {published data only} * Lücking CH, Oestreich W, Schmidt R, Soyka D. Flunarizine vs. propranolol in the prophylaxis of migraine: two double-blind comparative studies in more than 400 patients. Cephalalgia 1988;8 Suppl 8:22-6.
42. Soyka D, Oestreich W. Flunarizine versus propranolol in the interval treatment of migraine [Flunarizin versus Propranolol in der Intervallbehandlung der Migräne - multizentrische Doppelblindsudie bei niedergelassenen Allgemeinärzten und Internisten]. Nervenheilkunde 1990;9:45-51.
43. Soyka D, Oestreich W. Therapeutic effectiveness of flunarizine and propranolol in the interval therapy of migraine. Cephalalgia 1987;7 Suppl 6:467-8.
44. Maissen 1991 {published data only} Maissen CP, Ludin HP. Comparative efficacy of 5-hydroxytryptophan and propranolol in interval treatment of migraine [Vergleich der Wirksamkeit von 5-Hydroxytrypthophan und von Propranolol in der Intervalltherapie der Migräne]. Schweizerische Medizinische Wochenschrift. Journal Suisse de Medecine 1991;121(43): 1585-90.
45. Malvea 1973 {published data only} Malvea BP, Gwon N, Graham JR. Propranolol prophylaxis of migraine. Headache 1973;12(4):163-7.
46. Mathew 1981-Study 1 {published data only} Mathew NT. Prophylaxis of migraine and mixed headache. A randomized controlled study. Headache 1981;21(3):105-9. [Study 1 included patients with migraine only].
47. Mathew 1981-Study 2 {published data only} Mathew NT. Prophylaxis of migraine and mixed headache. A randomized controlled study. Headache 1981;21(3):105-9 [Study 2 included patients with migraine + interval headaches].
48. Micieli 2001 {published data only} Micieli G, Cavallini A, Marcheselli S, Mailland F, Ambrosoli L, Nappi G. Alpha-dihydroergocryptine and predictive factors in migraine prophylaxis. Int J Clin Pharmacol Ther 2001;39:155-151.
49. Mikkelsen 1986 {published data only} Mikkelsen B, Pedersen KK, Christiansen LV. Prophylactic treatment of migraine with tolfenamic acid, propanolol and placebo. Acta Neurologica Scandinavica 1986;73(4):423-7.
50. Nadelmann 1986 {published data only} Nadelmann JW, Phil M, Stevens J, Saper JR. Propranolol in the prophylaxis of migraine. Headache 1986;26(4):175-82.
51. Nicolodi 1997 {published data only} Nicolodi M, Del Bianco PL, Sicuteri F. The way to serotonergic use and abuse in migraine. International Journal of Clinical Pharmacology Research 1997;17(2-3):79-84.
52. Olerud 1986 {published data only} Olerud B, Gustavsson CL, Furberg B. Nadolol and propranolol in migraine management. Headache 1986;26(10):490-3.
53. Olsson 1984 {published data only} Olsson JE, Behring HC, Forssman B, Hedman C, Hedman G, Johansson F, et al.Metoprolol and propranolol in migraine prophylaxis: a double-blind multicentre study. Acta Neurologica Scandinavica 1984;70(3):160-8.
54. Palferman 1983 {published data only} Palferman TG, Gibberd FB, Simmonds JP. Prophylactic propranolol in the treatment of headache. British Journal of Clinical Practice 1983;37(1):28-9.
55. Pita 1977 {published data only} Pita E, Higueras A, Bolanos J, Perez N, Mundo A. Propranolol and migraine. A clinical trial. Archivos de Farmacologia y Toxicologia 1977;3(3):273-8.
56. Pradalier 1989 {published data only} Pradalier A, Serratrice G, Collard M, Hirsch E, Feve J, Masson M, et al.Beta-blockers and migraine. Efficacy of time-release propranolol versus placebo [Beta-bloquants et migraine. Efficacité, contre placebo, du propranolol a libération prolongée]. Thérapie 1990;45(5):441-5.
57. Pradalier A, Serratrice G, Collard M, Hirsch E, Feve J, Masson M, et al.Double-blind placebo controlled study of the use of long-acting propranolol in migraine prophylaxis. Cephalalgia 1989;9 Suppl 10:367-8.
58. * Pradalier A, Serratrice G, Collard M, Hirsch E, Feve J, Masson M, et al.Long-acting propranolol in migraine prophylaxis: results of a double-blind, placebo-controlled study. Cephalalgia 1989;9(4):247- 53.
59. Ryan 1984 {published data only} Ryan RE Sr. Comparative study of nadolol and propranolol in prophylactic treatment of migraine. American Heart Journal 1984;108(4 Pt 2):1156-9.
60. Sargent 1985 {published data only} Sargent J, Solbach P, Damasio H, Baumel B, Corbett J, Eisner L, et al.A comparison of naproxen sodium to propranolol hydrochloride and a placebo control for the prophylaxis of migraine headache. Headache 1985;25(6):320-4.
61. Scholz 1987 {published data only} Scholz E, Gerber WD, Diener HC, Langohr HD, Reinecke M. Dihydroergotamine vs flunarizine vs nifidepine vs metoprolol vs propranolol in migraine prophylaxis: a comparative study based on time series analysis. In: Rose CF editor(s). Advances in headache research: proceedings of the 6th International Migraine Symposium. London: John Libbey, 1987:139-45.
62. Shimell 1990 {published data only} Shimell CJ, Fritz VU, Levien SL. A comparative trial of flunarizine and propranolol in the prevention of migraine. South African Medical Journal 1990;77(2):75-7.
63. Solomon 1986 {published data only} Solomon GD, Scott AFB. Verapamil and propranolol in migraine prophylaxis: a double-blind, crossover study. Headache 1986;26(6):325.
64. Stensrud 1976 {published data only} Stensrud P, Sjaastad O. Short-term clinical trial of propranolol in racemic form (Inderal), D-propranolol and placebo in migraine. Acta Neurologica Scandinavica 1976;53(3):229-32.
65. Stensrud 1980 {published data only} * Stensrud P, Sjaastad O. Comparative trial of Tenormin (atenol) and Inderal (propranolol) in migraine. Headache 1980;20(4):204-7.
66. Stensrud P, Sjaastad O. Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine. Upsala Journal of Medical Sciences - Supplement 1980;31:37-40.
67. Sudilovsky 1987 {published data only} Sudilovsky A, Elkind AH, Ryan RE Sr, Saper JR, Stern MA, Meyer JH. Comparative efficacy of nadolol and propranolol in the management of migraine. Headache 1987;27(8):421-6.
68. Tfelt-Hansen 1984 {published data only} Standnes B. The prophylactic effect of timolol versus propranolol and placebo in common migraine: beta-blockers in migraine. Cephalalgia 1982;2(3):165-70.
69. * Tfelt-Hansen P, Standnes B, Kangasneimi P, Hakkarainen H, Olesen J. Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial. Acta Neurologica Scandinavica 1984;69(1):1-8.
70. Weber 1972 {published data only} Weber RB, Reinmuth OM. The treatment of migraine with propranolol. Neurology 1972;22(4):366-9.
71. Wideroe 1974 {published data only} Wideroe TE, Vigander T. Propranolol in the treatment of migraine. BMJ 1974;2(921):699- 701.
72. Ziegler 1987 {published data only} * Ziegler DK, Hurwitz A, Hassanein RS, Kodanaz HA, Preskorn SH, Manson J. Migraine prophylaxis. A comparison of propranolol and amitriptyline. Archives of Neurology 1987;44(5):486-9.
73. Ziegler DK, Hurwitz A, Preskorn S, Hassanein R, Seim J. Propranolol and amitriptyline in the prophylaxis of migraine. Pharmacokinetic and therapeutic effects. Archives of Neurology 1993;50(8):825-30.
74. Amery 1988 {published data only} Amery WK. Onset of action of various migraine prophylactics. Cephalalgia 1988;8 Suppl 8:11-3.
75. Anonymous 1979 {published data only} Anonymous. Propranolol for prevention of migraine headaches. Medical Letter on Drugs & Therapeutics 1979;21(19):77-8.
76. Banerjee 1991 {published data only} Banerjee M, Findley L. Propranolol in the treatment of acute migraine attacks. Cephalalgia 1991;11(4):193-6.
77. Carroll 1990 {published data only} Carroll JD, Reidy M, Savundra PA, Cleave N, McAinsh J. Long-acting propranolol in the prophylaxis of migraine: a comparative study of two doses. Cephalalgia 1990;10(2):101-5.
78. Cortelli 1985 {published data only} Cortelli P, Sacquegna T, Albani F, Baldrati A, D'Alessandro R, Baruzzi A, et al.Propranolol plasma levels and relief of migraine. Relationship between plasma propranolol and 4-hydroxypropranolol concentrations and clinical effects. Archives of Neurology 1985;42(1):46-8.
79. de Bock 1997 {published data only} de Bock GH, Eelhart J, van Marwijk HW, Tromp TP, Springer MP. A postmarketing study of flunarizine in migraine and vertigo. Pharmacy World & Science 1997;19(6):269- 74.
80. Diamond 1987 {published data only} Diamond S, Solomon GD, Freitag FG, Mehta ND. Long-acting propranolol in the prophylaxis of migraine. Headache 1987;27(2):70-2.
81. Fuller 1990 {published data only} Fuller GN, Guiloff RJ. Propranolol in acute migraine: a controlled study. Cephalalgia 1990;10(5):229-33.
82. Havanka-Kann. 1988 {published data only} Havanka-Kanniainen H, Hokkanen E, Myllylä VV. Long acting propranolol in the prophylaxis of migraine. Comparison of the daily doses of 80 mg and 160 mg. Headache 1988;28(9):607-11.
83. Holroyd 1995 {published data only} Holroyd KA, France JL, Cordingley GE, Rokicki LA, Kvaal SA, Lipchik GL, et al.Enhancing the effectiveness of relaxation-thermal biofeedback training with propranolol hydrochloride. Journal of Consulting & Clinical Psychology 1995;63(2):327-30.
84. Julien 1976 {published data only} Julien J, Vallat JM, Lagueny A, Darriet M. Preventive treatment of migraine with propranolol (letter) [Le traitement prophylactique des migraines par le propranolol]. Nouvelle Presse Médicale 1976;5(10):653.
85. Montastruc 1992 {published data only} Montastruc JL, Senard JM. Calcium channel blockers and prevention of migraine [Medicaments anticalciques et prophylaxie de la migraine]. Pathologie et Biologie 1992;40(4):381-8.
86. Penzien 1990 {published data only} Penzien D, Johnson C, Carpenter D, Holroyd K. Drug vs. behavioral treatment of migraine: long-acting propranolol vs. home-based self-management training. Headache 1990;30(5):300.
87. Raveau-Landon 1988 {published data only} Raveau-Landon C, Bousser MG. Metoprolol, a new effective antimigraine agent [Le metoprolo, nouvel antimigraineux de fond]. Presse Medicale 1988;17(35):1805- 9.
88. Rosen 1983 {published data only} Rosen JA. Observations on the efficacy of propranolol for the prophylaxis of migraine. Annals of Neurology 1983;13(1):92-3.
89. Schmidt 1991 {published data only} Schmidt R, Oestreich W. Flunarizine in migraine prophylaxis: the clinical experience. Journal of Cardiovascular Pharmacology 1991;18 Suppl 8:S21-6.
90. Sovak 1981 {published data only} Sovak M, Kunzel M, Sternbach RA, Dalessio DJ. Mechanism of the biofeedback therapy of migraine: volitional manipulation of the psychophysiological background. Headache 1981;21(3):89-92.
91. Steardo 1982 {published data only} Steardo L, Bonuso S, Di Stasio E, Marano E. Selective and nonselective beta-blockers: are both effective in prophylaxis of migraine? A clinical trial versus methysergide. Acta Neurologica 1982;4(3):196-204.
92. Tfelt-Hansen 1986 {published data only} Tfelt-Hansen P. Efficancy of beta-blockers in migraine. A critical review. Cephalalgia 1986;6 Suppl 5:15-24.
93. Turner 1984 {published data only} Turner P. Beta-blocking drugs in migraine. Postgraduate Medical Journal 1984;60 Suppl 2:51-5.
94. Verspeelt 1996a {published data only} Verspeelt J, De Locht P, Amery WK. Post-marketing cohort study comparing the safety and efficacy of flunarizine and propranolol in the prophylaxis of migraine. Cephalalgia 1996;16(5):328-36.
95. Verspeelt 1996b {published data only} Verspeelt J, De Locht P, Amery WK. Postmarketing study of the use of flunarizine in vestibular vertigo and in migraine. European Journal of Clinical Pharmacology 1996;51(1):15-22.
96. Winther 1990 {published data only} Winther K, Hedman C, Flodgaard H. Platelet P1, P4-Di (adenosine-51) tetraphosphate (AP4A) in migraine patients before and during beta-adrenoceptor blockade. European Journal of Clinical Investigation 1990;20(3):336-8.
97. Wober 1991 {published data only} Wober C, Wober-Bingel C, Koch G, Wessely P. Long-term results of migraine prophylaxis with flunarizine and beta-blockers. Cephalalgia 1991;11(6):251-6.
98. Bernik 1978 {published data only} Bernik V, Maia E. The use of propranolol on migraine prophylaxis: a double-blind clinical trials comparing propranolol with an analgesic drug (acetaminophen) and placebo [Uso do propranolol na profilaxia da enxacequa: Estudo duplo-cego comparando propranolol a um analgesico (acetaminofen) e placebo]. Folha médica (Rio de Janeiro) 1978;77(4):501-8.
99. Rao 2000 {published data only} Rao BS, Das DG, Taraknath VR, Sarma Y. A double blind controlled study of propranolol and cyproheptadine in migraine prophylaxis. Neurology India 2000;48(3):223-6.
100. Ad Hoc 1962 Ad Hoc Committee on the Classification of Headache of the National Institute of Neurological Diseases and Blindness. Classification of headache. JAMA 1962;179(9):717-8.
101. Clarke 2003 Clarke M, Oxman AD, editors. Optimal search strategy for RCTs. Cochrane Reviewers' Handbook 4.1.6 [updated January 2003]; Appendix 5c. In: The Cochrane Library, Issue 1, 2003. Oxford: Update Software.
102. Gray 1999 Gray RN, Goslin RE, McCrory DC, Eberlein K, Tulsky J, Hasselblad V. Drug treatments for the prevention of migraine headache. Technical review 2.3. February 1999. Prepared for the Agency for Health Care Policy and Research under Contract No. 290-94-2025. Available at: http://www.clinpol.mc. duke.edu (accessed 20 February 2004).
103. Holroyd 1991 Holroyd KA, Penzien DB, Cordingley GE. Propranolol in the management of recurrent migraine: a meta-analytic review. Headache 1991;31(5):333-40.
104. IHS 1988 Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8 Suppl 7:1-96.
105. Jadad 1996 Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al.Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1-12.
106. Lipton 2001 Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001;41(7):646-57.
107. Pryse-Phillips 1997 Pryse-Phillips WEM, Dodick DW, Edmeads JG, Gawel MJ, Nelson RF, Purdy RA, et al.Guidelines for the diagnosis and management of migraine in clinical practice [published erratum appears in CMAJ 1997;157(10):1354]. CMAJ 1997;156(9):1273-87.
108. Ramadan 1997 Ramadan NM, Schultz LL, Gilkey SJ. Migraine prophylactic drugs: proof of efficacy, utilization and cost. Cephalalgia 1997;17(2):73-80.
109. Stewart 1994 Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence. A review of population-based studies. Neurology 1994;44(6 Suppl 4):S17-S23.
110. Tfelt-Hansen 2000 Tfelt-Hansen P, Block G, Dahlöf C, Diener HC, Ferrari MD, Goadsby PJ, et al.Guidelines for controlled trials of drugs for migraine: second edition. Cephalalgia 2000;20(9):765-86.
111. Verhagen 1998 Verhagen AP, de Vet HCW, de Bie RA, Kessels AG, Boers M, Bouter LM, et al.The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. Journal of Clinical Epidemiology 1998;51(12):1235-41.